The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone

Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid ≤24 h after the operation, exceeded th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2001-04, Vol.47 (4), p.483-486
Hauptverfasser: Lovering, A. M., Walsh, T. R., Bannister, G. C., MacGowan, A. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 486
container_issue 4
container_start_page 483
container_title Journal of antimicrobial chemotherapy
container_volume 47
creator Lovering, A. M.
Walsh, T. R.
Bannister, G. C.
MacGowan, A. P.
description Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid ≤24 h after the operation, exceeded the MIC for susceptible staphylococci and would be expected to provide adequate prophylaxis. Although ceftriaxone concentrations in bone and fat were significantly higher than those of cefamandole, after correction for the simultaneous blood concentrations, we were unable to detect any differences in the bone or fat penetration of the two agents. We conclude that there is no evidence that cephalosporins with a lower serum protein binding penetrate bone better than ones with higher serum protein binding.
doi_str_mv 10.1093/jac/47.4.483
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76999026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>373959611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-bafd8c2952a37a4c517e59f825bd9fae62f982d121fcb59328ead8960ae6c7cc3</originalsourceid><addsrcrecordid>eNqFkkFvEzEQhVcIRNPCjTNagcSpm9per70-QgQtUhAgFYG4WLPeMXHY9QbbqcrP4B_jNFEQXDh5Ru_Tsz1viuIJJXNKVH2xBnPB5ZzPeVvfK2aUC1Ixouj9YkZq0lSSN_VJcRrjmhAiGtE-LE4oZUJwJmfFr-sVlhv0mAIkN_lysqVBm4KD28ljCb7f9TDmYhqwdD5NZZeV89JCupNXgCOkaYS7LuCAN-AN7pwihu1YbsKU0Pmyc753_luZHdIKXfjr3qPxo-KBhSHi48N5Vnx68_p6cVUt31--XbxcVoZzlaoObN8aphoGtQRuGiqxUbZlTdcrCyiYVS3rKaPWdI2qWYvQt0qQLBlpTH1WvNj75uf92GJMenTR4DCAx2kbtRRKKcLEf0Ha8pYqVmfw2T_getoGnz-hGZV59JzxDJ3vIROmGANavQluhPBTU6J3geocqOZSc50DzfjTg-e2G7H_Ax8SzMDzAwDRwGBDnr2LR05xkTciU9WecjHh7VGF8F0LWctGX335qj98lO8-Xy5f6UX9G_dOufI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217656424</pqid></control><display><type>article</type><title>The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Lovering, A. M. ; Walsh, T. R. ; Bannister, G. C. ; MacGowan, A. P.</creator><creatorcontrib>Lovering, A. M. ; Walsh, T. R. ; Bannister, G. C. ; MacGowan, A. P.</creatorcontrib><description>Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid ≤24 h after the operation, exceeded the MIC for susceptible staphylococci and would be expected to provide adequate prophylaxis. Although ceftriaxone concentrations in bone and fat were significantly higher than those of cefamandole, after correction for the simultaneous blood concentrations, we were unable to detect any differences in the bone or fat penetration of the two agents. We conclude that there is no evidence that cephalosporins with a lower serum protein binding penetrate bone better than ones with higher serum protein binding.</description><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/47.4.483</identifier><identifier>PMID: 11266427</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adipose Tissue - metabolism ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Blood Proteins - metabolism ; Body Fluids - metabolism ; Bone and Bones - metabolism ; Cefamandole - blood ; Cefamandole - pharmacokinetics ; Ceftriaxone - blood ; Ceftriaxone - pharmacokinetics ; Hematoma - metabolism ; Hip - surgery ; Hip Prosthesis ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Time Factors</subject><ispartof>Journal of antimicrobial chemotherapy, 2001-04, Vol.47 (4), p.483-486</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Apr 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-bafd8c2952a37a4c517e59f825bd9fae62f982d121fcb59328ead8960ae6c7cc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=946146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11266427$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lovering, A. M.</creatorcontrib><creatorcontrib>Walsh, T. R.</creatorcontrib><creatorcontrib>Bannister, G. C.</creatorcontrib><creatorcontrib>MacGowan, A. P.</creatorcontrib><title>The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J. Antimicrob. Chemother</addtitle><description>Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid ≤24 h after the operation, exceeded the MIC for susceptible staphylococci and would be expected to provide adequate prophylaxis. Although ceftriaxone concentrations in bone and fat were significantly higher than those of cefamandole, after correction for the simultaneous blood concentrations, we were unable to detect any differences in the bone or fat penetration of the two agents. We conclude that there is no evidence that cephalosporins with a lower serum protein binding penetrate bone better than ones with higher serum protein binding.</description><subject>Adipose Tissue - metabolism</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Blood Proteins - metabolism</subject><subject>Body Fluids - metabolism</subject><subject>Bone and Bones - metabolism</subject><subject>Cefamandole - blood</subject><subject>Cefamandole - pharmacokinetics</subject><subject>Ceftriaxone - blood</subject><subject>Ceftriaxone - pharmacokinetics</subject><subject>Hematoma - metabolism</subject><subject>Hip - surgery</subject><subject>Hip Prosthesis</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkFvEzEQhVcIRNPCjTNagcSpm9per70-QgQtUhAgFYG4WLPeMXHY9QbbqcrP4B_jNFEQXDh5Ru_Tsz1viuIJJXNKVH2xBnPB5ZzPeVvfK2aUC1Ixouj9YkZq0lSSN_VJcRrjmhAiGtE-LE4oZUJwJmfFr-sVlhv0mAIkN_lysqVBm4KD28ljCb7f9TDmYhqwdD5NZZeV89JCupNXgCOkaYS7LuCAN-AN7pwihu1YbsKU0Pmyc753_luZHdIKXfjr3qPxo-KBhSHi48N5Vnx68_p6cVUt31--XbxcVoZzlaoObN8aphoGtQRuGiqxUbZlTdcrCyiYVS3rKaPWdI2qWYvQt0qQLBlpTH1WvNj75uf92GJMenTR4DCAx2kbtRRKKcLEf0Ha8pYqVmfw2T_getoGnz-hGZV59JzxDJ3vIROmGANavQluhPBTU6J3geocqOZSc50DzfjTg-e2G7H_Ax8SzMDzAwDRwGBDnr2LR05xkTciU9WecjHh7VGF8F0LWctGX335qj98lO8-Xy5f6UX9G_dOufI</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Lovering, A. M.</creator><creator>Walsh, T. R.</creator><creator>Bannister, G. C.</creator><creator>MacGowan, A. P.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone</title><author>Lovering, A. M. ; Walsh, T. R. ; Bannister, G. C. ; MacGowan, A. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-bafd8c2952a37a4c517e59f825bd9fae62f982d121fcb59328ead8960ae6c7cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adipose Tissue - metabolism</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Blood Proteins - metabolism</topic><topic>Body Fluids - metabolism</topic><topic>Bone and Bones - metabolism</topic><topic>Cefamandole - blood</topic><topic>Cefamandole - pharmacokinetics</topic><topic>Ceftriaxone - blood</topic><topic>Ceftriaxone - pharmacokinetics</topic><topic>Hematoma - metabolism</topic><topic>Hip - surgery</topic><topic>Hip Prosthesis</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lovering, A. M.</creatorcontrib><creatorcontrib>Walsh, T. R.</creatorcontrib><creatorcontrib>Bannister, G. C.</creatorcontrib><creatorcontrib>MacGowan, A. P.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lovering, A. M.</au><au>Walsh, T. R.</au><au>Bannister, G. C.</au><au>MacGowan, A. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J. Antimicrob. Chemother</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>47</volume><issue>4</issue><spage>483</spage><epage>486</epage><pages>483-486</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Thirteen patients undergoing total hip replacement were given ceftriaxone 1 g and cefamandole 1 g simultaneously, either immediately or 8 h before surgery. For both agents the concentrations seen in the bone and fat during the operation, and for haematoma fluid ≤24 h after the operation, exceeded the MIC for susceptible staphylococci and would be expected to provide adequate prophylaxis. Although ceftriaxone concentrations in bone and fat were significantly higher than those of cefamandole, after correction for the simultaneous blood concentrations, we were unable to detect any differences in the bone or fat penetration of the two agents. We conclude that there is no evidence that cephalosporins with a lower serum protein binding penetrate bone better than ones with higher serum protein binding.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11266427</pmid><doi>10.1093/jac/47.4.483</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2001-04, Vol.47 (4), p.483-486
issn 0305-7453
1460-2091
1460-2091
language eng
recordid cdi_proquest_miscellaneous_76999026
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Adipose Tissue - metabolism
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Blood Proteins - metabolism
Body Fluids - metabolism
Bone and Bones - metabolism
Cefamandole - blood
Cefamandole - pharmacokinetics
Ceftriaxone - blood
Ceftriaxone - pharmacokinetics
Hematoma - metabolism
Hip - surgery
Hip Prosthesis
Humans
Medical sciences
Pharmacology. Drug treatments
Time Factors
title The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A27%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20penetration%20of%20ceftriaxone%20and%20cefamandole%20into%20bone,%20fat%20and%20haematoma%20and%20relevance%20of%20serum%20protein%20binding%20to%20their%20penetration%20into%20bone&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Lovering,%20A.%20M.&rft.date=2001-04-01&rft.volume=47&rft.issue=4&rft.spage=483&rft.epage=486&rft.pages=483-486&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/47.4.483&rft_dat=%3Cproquest_cross%3E373959611%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217656424&rft_id=info:pmid/11266427&rfr_iscdi=true